Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.Founded in 2003, Acceleron Pharma is an established company that loves to hire graduates from Northeastern University, with 36.4% of its employees having attended Northeastern University. Want to compare Acceleron Pharma to some other great places to work in Cambridge, MA? We suggest taking a look at Zippia's list of Best Companies to Work For in Cambridge, MA.The average employee at Acceleron Pharma makes $70,914 per year. Pay at Acceleron Pharma is significantly lower than some of its highest paying competitors, like Exelixis, Gilead Sciences, and Vertex Pharmaceuticals, which pay $108,978, $99,828, and $95,952, respectively.Based in Cambridge, MA, Acceleron Pharma is a medium-sized health care company with 312 employees and a revenue of $92.5M.
Acceleron Pharma's mission statement
Our mission is to build a portfolio of innovative medicines that transform patients' lives by leveraging our research and expertise in the TGF-beta superfamily.
In demand companies are hiring! Let Zippia apply for you!
5.0/5
Acceleron Pharma employee reviews
Based on 1 ratings
Do you work at Acceleron Pharma?
Help job seekers learn about working at Acceleron Pharma
At my time the Company built a Team treating each other equally
Cons of working at Acceleron Pharma
N/A
Acceleron Pharma benefits
Everything were great
Is this useful?
The team at Acceleron Pharma
The founders of Acceleron Pharma are John L Knopf, Tom Maniatis, Christoph Westphal, Jasbir Seehra, Lon Nebiolini, Mark Ptashne and Wylie Vale.
The key people at Acceleron Pharma are Habib J. Dable, John L Knopf and Tom Maniatis.
Key people
Habib J. Dable
John L Knopf
Tom Maniatis
Christoph Westphal
Jasbir Seehra
Lon Nebiolini
Mark Ptashne
Wylie Vale
Acceleron Pharma salaries
Average Acceleron Pharma salary
$70,914
yearly
$34.09 hourly
Updated March 14, 2024
Rate Acceleron Pharma's commitment to diversity and inclusion.
Acceleron Pharma diversity
6.6
Diversity score
We calculated Acceleron Pharma’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Acceleron Pharma’s workforce.
Acceleron Pharma diversity summary. Zippia estimates Acceleron Pharma's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Acceleron Pharma's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Acceleron Pharma's workforce.
Acceleron Pharma has 312 employees.
47% of Acceleron Pharma employees are women, while 53% are men.
The most common ethnicity at Acceleron Pharma is White (63%).
19% of Acceleron Pharma employees are Asian.
8% of Acceleron Pharma employees are Hispanic or Latino.
The average employee at Acceleron Pharma makes $70,914 per year.
Employees at Acceleron Pharma stay with the company for 2.5 years on average.
Do you work at Acceleron Pharma?
Does Acceleron Pharma actively promote diversity and inclusion?
Acceleron Pharma financial performance
9.4
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Acceleron Pharma currently has 92.5M in revenue. Acceleron Pharma's most recent quarter produced 34.2m (q3'2021).
Acceleron Pharma annual revenue
$93M
$74M
$56M
$37M
$19M
$0
2015
2016
2017
2018
2019
2020
Highest paying Acceleron Pharma competitors
Compare Acceleron Pharma salaries to competitors, including Exelixis, Gilead Sciences, and Vertex Pharmaceuticals. Employees at Exelixis earn the highest average yearly salary of $108,978. The salaries at Gilead Sciences average $99,828 per year, and the salaries at Vertex Pharmaceuticals come in at $95,952 per year.
Rank
Company
Average salary
Jobs
1
$108,978
0
2
$99,828
0
3
$95,952
0
4
$93,349
0
5
$91,901
0
6
$89,800
0
7
$87,092
0
8
$85,589
0
9
$85,008
0
10
$81,825
0
Show more
Are you an executive, HR leader, or brand manager at Acceleron Pharma?
Claiming and updating your company profile on Zippia is free and easy.
Zippia gives an in-depth look into the details of Acceleron Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Acceleron Pharma. The employee data is based on information from people who have self-reported their past or current employments at Acceleron Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Acceleron Pharma. The data presented on this page does not represent the view of Acceleron Pharma and its employees or that of Zippia.
Acceleron Pharma may also be known as or be related to ACCELERON PHARMA INC, Acceleron Pharma, Acceleron Pharma Inc, Acceleron Pharma Inc. and Acceleron Pharma, Inc.
